Abstract
SummaryThe effects of ‡-ACA, a potent inhibitor of plasminogen activation, on in vitro pre-formed clot lysis and plasma plasminogen activation by SK have been studied. Complete inhibition of plasma plasminogen activation by ‡-ACA has been demonstrated to occur with little concomitant effect on the dissolution of a clot immersed in plasma. Rate of clot dissolution by SK is shown to be a function of clot plasminogen concentration. Potential clinical applications are discussed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
